找化学品上960化工网!
960化工网

3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮 | 867165-62-6

3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮
3-(8-Chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)cyclobutanone
867165-62-6
C25H17ClN4O
424.881684064865
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮结构式
名称和标识符
MDL MFCD22124607
InChIKey LEJRWMNNXWPDNP-UHFFFAOYSA-N
Inchi 1S/C25H17ClN4O/c26-24-23-22(29-25(18-12-19(31)13-18)30(23)11-10-27-24)17-7-6-16-8-9-20(28-21(16)14-17)15-4-2-1-3-5-15/h1-11,14,18H,12-13H2
SMILES O=C1CC(C2N3C(C(=NC=C3)Cl)=C(C3C=C4C(C=CC(C5C=CC=CC=5)=N4)=CC=3)N=2)C1
别名信息
- 中文别名 -
  • 3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮
  • 3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-A]吡嗪-3-基)环丁酮
  • 3-(8-chloro-1-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-3-yl)cyclobutanone
- 英文别名 -
  • 3-(8-Chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)cyclobutanone
  • 3-[8-Chloro-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]c yclobutanone
  • 3-[8-chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanone
  • LEJRWMNNXWPDNP-UHFFFAOYSA-N
  • 3-[8-Chloro-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanone (ACI)
物化性质
计算特性
氢键供体数量 0
氢键受体数量 4
可旋转化学键数量 3
重原子数量 31
复杂度 662
拓扑分子极性表面积 60.2
合成路线

合成路线:6 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:7 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:4 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:1 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:2 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:3 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375

合成路线:5 步

反应条件:
参考文献:
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
Mulvihill, Mark J.; et al, Bioorganic & Medicinal Chemistry, 2008, 16(3), 1359-1375
3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮推荐生产厂家
960化工网为您提供3-(8-氯-1-(2-苯基喹啉-7-基)咪唑并[1,5-a]吡嗪-3-基)环丁烷酮专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:867165-62-6,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:867165-62-6
平台客服 平台客服

平台在线客服